Page last updated: 2024-11-03

pyrimethamine and Cushing Syndrome

pyrimethamine has been researched along with Cushing Syndrome in 1 studies

Maloprim: contains above 2 cpds

Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camanni, F1
Losana, O1
Massara, F1
Molinatti, GM1

Other Studies

1 other study available for pyrimethamine and Cushing Syndrome

ArticleYear
Increased renal phosphate excretion in Cushing's syndrome.
    Acta endocrinologica, 1967, Volume: 56, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adult; Cushing Syndrome; Dexamethasone; Female; Humans; Kidne

1967